ReviewProceedings of the National Academy of Sciences of the United States of America2019
Targeting RIPK1 for the treatment of human diseases.
Alexei Degterev et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
221 papers cite itlatest 60 shown
this paperpooled ittrialcites it